health care industry: pharmaceutical companies, health insurance plans, national pharmacy chains, pharmacy benefit managers, and the federal government
Disclosures The authors Saman Tauqir, Momina Israr, Bushra Rauf, Muhammad Omar Malik, Syed Hamid Habib, Fawad Ali Shah, Muhammad Usman, Muhammad Asif Raza, Inayat Shah, Haroon Badshah, Ehtesham Ehtesham, and Mohsin Shah have nothing to disclose
But what is likely is that by decreasing obesity, a risk factor, people get less endometrial cancer. Tangir said the GLP-1s also are curbing a pre-cancer condition in the uterine lining called complex atypical hyperplasia
247 In another trial, patients with type 2 diabetes who also had mild-to-moderate symptoms of anxiety and depression received either 30 mg saffron extract or placebo daily for eight weeks
It's a must-read for anyone considering adding GLP-1s to their weight loss journey